CTRI/2018/07/014830
Recruiting
未知
Comparative Evaluation Of Two Antiemetic Combination OF Palenosetron-Dexamethasone Versus Granisetron-Dexamethasone in Patients Undergoing Elective Laproscopic Surgery
Dr RPGMC TANDA0 sites84 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Dr RPGMC TANDA
- Enrollment
- 84
- Status
- Recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients in the age group of 20\-60 years.
- •1\.ASA I â??II
- •2\.Patient willing to give consent for study.
- •3\.No history of motion sickness.
- •4\.No previous history of PONV.
- •5\.Nonsmoker.
Exclusion Criteria
- •1\.Patients not giving consent for study.
- •2\.Patients with history of taking drugs responsible for antiemetic action for eg. steroids etc.
- •4\.Patient with gastrointestinal reflux diseases.
- •5\.Patient with history of PONV or motion sickness and those who had allergy to the study drugs or received antiemetic within 48 h before surgery.
- •6\.Pregnancy and lactation.
- •7\. Body mass index \>35 kg/m2\.
- •8\.Patients with Baseline prolonged QTc interval.
- •9\. Patients with electrolyte imbalances.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 2
Clinical evaluation of two antiemetic combinations palonosetron dexamethazone in paclitaxel and carboplatin: a randomized phase II trial.patients with gynecological malignancies who are receiving paclitaxel/carboplatin.JPRN-UMIN000007491ara Medical University80
Recruiting
Phase 3
Prophylactic antiemetic effects of Ondansetron and Haloperidol patients undergoing mastectomy- double-blind clinical trialIRCT20240224061097N1Iran University of Medical Sciences50
Completed
Phase 4
Combination Antiemetic Regimen for Prevention of PONV in Breast Surgery PatientsPostoperative Nausea and VomitingNCT00738621Scott and White Hospital & Clinic100
Completed
Phase 3
The efficacy of combination antiemetic therapy with Olanzapine, Palonosetron and dexamethasone for the prevention of nausea and vomiting in patients receiving Moderately Emetogenic Chemotherapygastric cancer, colorectal cancerJPRN-UMIN000034383Osaka Medical Collage150
Completed
Not Applicable
Comparison of antiemetic effectiveness and safety of palonosetron and dexamethasone with palonosetron, dexamethasone and aprepitant in patients with lung cancer receiving combination therapy with carboplatin: A phase II randomized studyJPRN-UMIN000010056Hamamatsu University School of Medicine80